Clinical trial
A Study Of Oral Paricalcitol To Treat Proteinuric Renal Disease
NCT00469625 · Winthrop University Hospital, Other · Withdrawn
Key facts
| NCT number | NCT00469625 |
|---|---|
| Title | A Study Of Oral Paricalcitol To Treat Proteinuric Renal Disease |
| Official title | A Study Of Oral Paricalcitol To Treat Proteinuric Renal Disease |
| Lead sponsor | Winthrop University Hospital, Other |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Proteinuric Renal Disease |
| Intervention type | Drug |
| Interventions | paricalcitol (initial dose 1 mcg orally per day) |
| Enrollment | 0 |
| Start date | Jul 1, 2006 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | May 4, 2007 |
| Last update posted | Dec 28, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: